(No ratings)
Dr. Thomas Carlton Hofstra, MD is a pediatric oncologist in Los Angeles, CA specializing in pediatric hematology/oncology. He graduated from Loyola University Chicago, Stritch School of Medicine. Dr. Thomas Carlton Hofstra, MD is affiliated with Children's Hospital Los Angeles and CHILDRENS HOSPITAL LOS ANGELES MEDICAL GROUP INC.
4650 W Sunset Boulevard
Los Angeles, CA 90027
Anemia
Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.
An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.
Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.
Hemophilia
Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:
Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.
Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.
Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.
Dr. Thomas Carlton Hofstra, MD graduated from Loyola University Chicago, Stritch School of Medicine. He completed residency at Loyola University Affiliated Hospitals. He is certified by the Pediatrics: American Board of Pediatrics Pediatric Hematology-Oncology: American Board of Pediatrics and has a state license in California.
Medical School: Loyola University Chicago, Stritch School of Medicine
Residency: Loyola University Affiliated Hospitals
Board Certification: Pediatrics: American Board of Pediatrics Pediatric Hematology-Oncology: American Board of Pediatrics
Licensed In: California
Dr. Thomas Carlton Hofstra, MD is associated with these hospitals and organizations:
Dr. Thomas Carlton Hofstra, MD does not have any reviews yet, be the first to leave a review of Dr. Thomas Carlton Hofstra, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Thomas Carlton Hofstra, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Novo Nordisk Inc |
$181
Novoeight $122 |
NovoSeven RT $27 |
$32 |
|||
---|---|---|---|---|---|---|
Genentech, Inc. |
$50
$50 |
|||||
Novartis Pharmaceuticals Corporation |
$36
ADAKVEO $24 |
Exjade $11 |
||||
Bio Products Laboratory USA, Inc. |
$26
Coagadex $26 |
|||||
Alexion Pharmaceuticals, Inc. |
$22
ANDEXXA $22 |
|||||
Other |
$90
ANDEXXA $20 |
Reblozyl $17 |
Sensors - Advanced Parameters $15 |
OXBRYTA $14 |
GAMIFANT $13 |
Other $10 |
Food and Beverage | $373 |
---|---|
Education | $32 |
Dr. Thomas Carlton Hofstra, MD has received 2 research payments totaling $2,222.
Dr. Thomas Hofstra is a medical specialist in pediatric hematology/oncology. His education and training includes medical school at Loyola University Chicago, Stritch School of Medicine and residency at a hospital affiliated with Loyola University. He is affiliated with Children's Hospital Los Angeles.